- Home
- GRWG vs NRSN Comparison
GRWG vs NRSN Comparison
Compare GRWG & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRWG
- NRSN
- Stock Information
- Founded
- GRWG 2008
- NRSN 2017
- Country
- GRWG United States
- NRSN Israel
- Employees
- GRWG N/A
- NRSN N/A
- Industry
- GRWG RETAIL: Building Materials
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- GRWG Consumer Discretionary
- NRSN Health Care
- Exchange
- GRWG Nasdaq
- NRSN Nasdaq
- Market Cap
- GRWG 59.4M
- NRSN 50.1M
- IPO Year
- GRWG N/A
- NRSN 2021
- Fundamental
- Price
- GRWG $1.10
- NRSN $2.03
- Analyst Decision
- GRWG Buy
- NRSN Buy
- Analyst Count
- GRWG 4
- NRSN 2
- Target Price
- GRWG $2.38
- NRSN $14.00
- AVG Volume (30 Days)
- GRWG 856.9K
- NRSN 245.4K
- Earning Date
- GRWG 08-07-2025
- NRSN 08-05-2025
- Dividend Yield
- GRWG N/A
- NRSN N/A
- EPS Growth
- GRWG N/A
- NRSN N/A
- EPS
- GRWG N/A
- NRSN N/A
- Revenue
- GRWG $176,681,000.00
- NRSN N/A
- Revenue This Year
- GRWG N/A
- NRSN N/A
- Revenue Next Year
- GRWG N/A
- NRSN N/A
- P/E Ratio
- GRWG N/A
- NRSN N/A
- Revenue Growth
- GRWG N/A
- NRSN N/A
- 52 Week Low
- GRWG $0.82
- NRSN $0.60
- 52 Week High
- GRWG $2.47
- NRSN $2.60
- Technical
- Relative Strength Index (RSI)
- GRWG 53.70
- NRSN 52.44
- Support Level
- GRWG $0.96
- NRSN $1.83
- Resistance Level
- GRWG $1.21
- NRSN $2.10
- Average True Range (ATR)
- GRWG 0.06
- NRSN 0.13
- MACD
- GRWG 0.02
- NRSN -0.01
- Stochastic Oscillator
- GRWG 56.00
- NRSN 57.75
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.